Epstein Secrets

ing prisoners awaiting the death penalty for the first time in 16 years." The AP (7/25, Balsamo, Long) reports Attorney General Barr has instructed the Bureau of Prisons to "resume executing federal death-row inmates...ending an informal, two-decade moratorium." The first five men to be executed are "all accused of

ple, including two children." According to Reuters (7/25, Lynch), "Early in the Trump administration, former Attorney General Jeff Sessions ordered the Federal Bureau of Prisons to examine what steps might be required to resume the use of the death penalty," and in March 2018, Sessions "also called on federal prosecutors to

ed in an indictment returned in U.S. District Court Wednesday of accepting more than $109,000 in kickbacks between 2012 and 2016 from Arizona-based Insys Therapeutics." Prosecutors "said she took sham speaking fees to more broadly prescribe an oral fentanyl spray approved for a specific type of cancer pain." CYB

nst him. A few hours later, on the overnight shift, only 18 workers were guarding a jail with roughly 750 inmates, according to records released by the Bureau of Prisons. Ten of the workers were on overtime. One post was actually vacant, the records show. On 9 South, the special unit where Mr. Epstein was housed, th

in connection with a scheme to prescribe Subsys, a potent fentanyl-based spray, in exchange for bribes and kickbacks from the drug's manufacturer, Insys Therapeutics. Jeffrey Goldstein, 49, prescribed his patients Subsys in exchange for close to $200,000 in bribes and kickbacks from the drug's manufacturer, as w

nst him. A few hours later, on the overnight shift, only 18 workers were guarding a jail with roughly 750 inmates, according to records released by the Bureau of Prisons. Ten of the workers were on overtime. One post was actually vacant, the records show. On 9 South, the special unit where Mr. Epstein was housed, th

in connection with a scheme to prescribe Subsys, a potent fentanyl-based spray, in exchange for bribes and kickbacks from the drug's manufacturer, Insys Therapeutics. Jeffrey Goldstein, 49, prescribed his patients Subsys in exchange for close to $200,000 in bribes and kickbacks from the drug's manufacturer, as w